A0A097J809 (A0A097J809_BPT4) Enterobacteria phage RB59
Endolysin UniProtKBAFDB90v4InterProInteractive Modelling
164 aa; Sequence (Fasta) ;
3 identical sequences: Enterobacteria phage RB55: A0A097J792; Escherichia phage T4: A0A7S9SVX7; Enterobacteria phage T4: D9IEF7
Available Structures
71 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
The cryoEM structure of human gamma-Secretase complex |
Heteromer D9IEF7; P49768; Q92542; | |||||
Assess | ||||||
Crystal structure of the Ca2+-free T4L-MICU1-MICU2 complex |
Heteromer D9IEF7; Q8IYU8; Q9BPX6; | |||||
Assess | ||||||
Muscarinic acetylcholine receptor 1 - muscarinic toxin 7 complex |
Heteromer D9IEF7; P11229; Q8QGR0; | 1×ACM; 4×Y01; 1×OIN; | ||||
Assess | ||||||
Structure of human beta1 adrenergic receptor bound to BI-167107 and nanobody 6B9 |
Heteromer D9IEF7; P08588; | 2×GLC; 6×SO4; 1×CLR; 1×1WV; 1×NA; 1×EPE; 1×P0G; 1×P6G; | ||||
Assess | ||||||
Structure of human beta1 adrenergic receptor bound to norepinephrine and nanobody 6B9 |
Heteromer D9IEF7; P08588; | 1×GLC; 1×E5E; 7×SO4; 1×NA; 1×EPE; 1×480; 1×CLR; 1×PG4; | ||||
Assess | ||||||
Structure of human beta1 adrenergic receptor bound to epinephrine and nanobody 6B9 |
Heteromer D9IEF7; P08588; | 1×ALE; 6×SO4; 1×NA; 1×EPE; 1×CLR; 1×1WV; | ||||
Assess | ||||||
Mechanism of Phosphate Sensing and Signaling Revealed by Rice SPX1-PHR2 Complex Structure |
Heteromer D9IEF7; Q69XJ0; Q6Z156; | 2×IHP; | ||||
Assess | ||||||
Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist |
Heteromer D9IEF7; P21728; P59768; P62873; P63092; | 1×VFP; 1×1PE; | ||||
Assess | ||||||
Structure of drosophila STING in complex with 3'2'-cGAMP | homo-2-mer | 1×4UR; | ||||
Assess | ||||||
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, pH10 | monomer | 2×GOL; 1×HEZ; | ||||
Assess | ||||||
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, pH7 | monomer | 2×HEZ; 2×GOL; 3×NA; | ||||
Assess | ||||||
T4 lysozyme with a 2,6-diazaadamantane nitroxide (DZD) spin label | monomer | 2×BME; 1×X8R; 2×K; 3×CL; | ||||
Assess | ||||||
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, pH4 | monomer | 3×GOL; 2×HEZ; 1×PO4; 1×NA; | ||||
Assess | ||||||
Structure of DCN1 bound to N-((4S,5S)-7-ethyl-4-(4-fluorophenyl)-3-methyl-6-oxo-1-phenyl-4,5,6,7-te… | monomer | 1×MPD; 1×O37; | ||||
Assess | ||||||
Spin-labeled T4 Lysozyme (9/131FnbY)-(4-Amino-TEMPO) | monomer | 2×QPM; | ||||
Assess | ||||||
Structure of DCN1 bound to N-((4S,5S)-3-(aminomethyl)-7-ethyl-4-(4-fluorophenyl)-6-oxo-1-phenyl-4,5… | monomer | 1×YHP; | ||||
Assess | ||||||
Structure of DCN1 bound to 3-methyl-N-((4S,5S)-3-methyl-6-oxo-1-phenyl-4-(p-tolyl)-4,5,6,7-tetrahyd… | monomer | 1×O0A; | ||||
Assess | ||||||
Structure of Spin-labelled T4 lysozyme mutant L115C-R119C-R1 at room temperature | monomer | |||||
Assess | ||||||
Structure of the drosophila STING cyclic dinucleotide binding domain | monomer | |||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME-GSS-PEPTIDE IN COMPLEX WITH TEICOPLANIN-A2-2 | monomer | 1×GCS; 1×T55; 1×NAG; 1×MAN; 2×PO4; 2×GOL; | ||||
Assess | ||||||
MTSL labelled T4 lysozyme pseudo-wild type V75C mutant | monomer | 1×MTN; 1×CL; | ||||
Assess | ||||||
DCN1 bound to DI-1859 | monomer | 1×H8S; | ||||
Assess | ||||||
DCN1 bound to inhibitor 10 | monomer | 1×H9P; | ||||
Assess | ||||||
DCN1 covalently bound to inhibitor 4 | monomer | 1×H9S; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF T4 LYSOZYME-PEPTIDE IN COMPLEX WITH TEICOPLANIN-A2-2 | monomer | 1×GCS; 1×NAG; 1×MAN; 1×T55; 1×CL; 1×NA; 1×PO4; 1×GOL; | ||||
Assess | ||||||
DCN1 bound to DI-1548 | monomer | 1×H8S; | ||||
Assess | ||||||
Neutron crystal structure of T4L M6AE | monomer | |||||
Assess | ||||||
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, DMSO 40%, and then backsoaking | monomer | 2×GOL; 4×NA; 2×CL; | ||||
Assess | ||||||
DCN1 bound to 8 | monomer | 1×EDO; 1×H8V; | ||||
Assess | ||||||
PI4K IIalpha bound to calcium | monomer | 2×ATP; 2×CA; | ||||
Assess | ||||||
Crystal structure of phosphatidyl inositol 4-kinase II alpha in complex with nucleotide analog | monomer | 1×M59; 1×ADP; | ||||
Assess | ||||||
Crystal structure of phosphatidyl inositol 4-kinase II alpha in complex with ATP | monomer | 2×ATP; | ||||
Assess | ||||||
DCN1 bound to inhibitor 9 | monomer | 1×H9M; | ||||
Assess | ||||||
T4 lysozyme mutant-S44C/C54T/N68C/A93C/C97A/T115C, DMSO 20% | monomer | 2×GOL; 3×DMS; 2×HEZ; 1×NA; 1×CL; | ||||
Assess | ||||||
T4 lysozyme pseudo-wild type soaked in TEMPOL | monomer | 2×CL; 1×HED; 1×PO4; | ||||
Assess | ||||||
T4 lysozyme pseudo-wild type soaked in TEMPO | monomer | 2×CL; 1×HED; | ||||
Assess | ||||||
MTSL labelled T4 lysozyme pseudo-wild type K65C mutant | monomer | 2×CL; 1×MTN; 1×HED; | ||||
Assess | ||||||
The crystal structure of Neisseria gonorrhoeae DolP (NGO1985) | monomer | 2×CL; | ||||
Assess | ||||||
T4 lysozyme mutant L99A in complex with 3-butylpyridine | monomer | 1×Y8J; 2×BME; 1×TRS; | ||||
Assess | ||||||
T4 lysozyme mutant L99A | monomer | 1×YGS; 1×BME; 1×TRS; | ||||
Assess | ||||||
Crystal Structure of human mARC1 A165T Variant | monomer | 1×EFK; 1×MTE; 1×B3P; 1×CL; | ||||
Assess | ||||||
Crystal structure of the N-terminal domain of the human mitochondrial calcium uniporter fused with … | monomer | 3×SO4; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Timolol to Alprenolol. | monomer | 1×JTZ; 1×CLR; 7×OLB; 3×OLC; 4×SO4; 4×OLA; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Timolol to Carvedilol. | monomer | 1×CVD; 4×SO4; 1×CLR; 6×OLC; 4×OLA; | ||||
Assess | ||||||
Crystal structure of the N-terminal domain single mutant (S92E) of the human mitochondrial calcium … | monomer | 2×SO4; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Timolol to ICI-118551. | monomer | 1×JRZ; 3×SO4; 1×CLR; 4×OLA; 10×OLC; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Timolol to Timolol. | monomer | 1×TIM; 4×SO4; 1×CLR; 7×OLC; 4×OLA; | ||||
Assess | ||||||
Crystal structure of the N-terminal domain single mutant (S92A) of the human mitochondrial calcium … | monomer | 6×SO4; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Alprenolol to Alprenolol. | monomer | 1×JTZ; 1×CLR; 3×OLC; 2×OLA; 4×SO4; | ||||
Assess | ||||||
Crystal structure of the N-terminal domain single mutant (D119A) of the human mitochondrial calcium… | monomer | 4×SO4; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Timolol to Propranolol. | monomer | 1×SNP; 4×SO4; 1×CLR; 2×OLA; 4×OLC; | ||||
Assess | ||||||
Haloperidol bound D2 dopamine receptor structure inspired discovery of subtype selective ligands | monomer | 1×GMJ; 4×OLA; | ||||
Assess | ||||||
The beta2 adrenergic receptor bound to a negative allosteric modulator | monomer | 2×CLR; 1×JTZ; 1×M3J; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Alprenolol to Timolol. | monomer | 1×TIM; 3×SO4; 1×CLR; 2×OLC; 1×OLA; | ||||
Assess | ||||||
XFEL beta2 AR structure by ligand exchange from Alprenolol to Carazolol. | monomer | 1×CAU; 3×SO4; 1×CLR; 3×OLC; 1×OLA; | ||||
Assess | ||||||
Crystal structure of A2AR-T4L in complex with 2-118 | monomer | 1×VBF; 1×CLR; 18×OLA; 1×NA; 1×OLC; | ||||
Assess | ||||||
Crystal structure of A2AR-T4L in complex with AB928 | monomer | 18×OLA; 1×NA; 2×OLC; 1×U30; 1×PEG; 1×CLR; | ||||
Assess | ||||||
Structure of human beta1 adrenergic receptor bound to carazolol | monomer | 1×CLR; 1×CAU; 6×SO4; 1×1WV; 1×NA; 2×CIT; 3×PG4; | ||||
Assess | ||||||
Structure of the M5 muscarinic acetylcholine receptor (M5-T4L) bound to tiotropium | monomer | 2×OLA; 1×0HK; 1×P33; 1×OLC; | ||||
Assess | ||||||
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with SQ1… | monomer | 1×3RX; 9×LMT; 2×MHA; | ||||
Assess | ||||||
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis | monomer | 2×MHA; 4×L6T; | ||||
Assess | ||||||
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with ICA… | monomer | 2×MHA; 5×L6T; 1×J9E; | ||||
Assess | ||||||
Crystal structure of human G protein coupled receptor | monomer | 1×9JU; 1×OLA; 3×OLC; 2×PEG; 2×EPE; 1×PG4; 5×SO4; | ||||
Assess | ||||||
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with AU1… | monomer | 1×9ZF; 5×L6T; 3×MHA; | ||||
Assess | ||||||
Crystal structure of mycolic acid transporter MmpL3 from Mycobacterium smegmatis complexed with Rim… | monomer | 1×AY6; 3×L6T; 2×MHA; | ||||
Assess | ||||||
Structure of beta2 adrenergic receptor fused to a Gs peptide | monomer | 1×P0G; | ||||
Assess | ||||||
Leukotriene B4 receptor BLT1 in complex with BIIL260 | monomer | 1×7Y9; | ||||
Assess | ||||||
X-ray structure of yeast dynein motor domain in the presence of a pyrazolo-pyrimidinone-based compo… | monomer | |||||
Assess | ||||||
XFEL crystal structure of the prostaglandin D2 receptor CRTH2 in complex with 15R-methyl-PGD2 | monomer | 1×YSS; 1×NA; 1×FLC; 5×SO4; | ||||
Assess | ||||||
M3-mT4L receptor bound to tiotropium | monomer | 1×0HK; 3×P6G; 2×TAR; | ||||
Assess | ||||||
M3-mT4L receptor bound to NMS | monomer | 1×TAR; 1×3C0; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1t6h.1.A | monomer | 0.89 | 100.00 | |||
Assess |